Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 55150-266

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 55150-266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Zoledronic Acid Fig1)

A bar graph titled 'Proportion of Complete Responders by Day 10 In Pooled HCM Studies' comparing Zoledronic Acid 4 mg (n=86) and Pamidronate 90 mg (n=99) by percentage of complete responders. The graph shows a higher proportion of complete responders with Zoledronic Acid 4 mg compared to Pamidronate 90 mg, with a p-value of 0.002 indicating statistical significance.*

FDA Label Image

Package Label-principal Display Panel (4 mg per 5 mL (0.8 mg / mL))

Label for Zoledronic Acid Injection 4 mg per 5 mL (0.8 mg/mL) solution concentrate for intravenous infusion after dilution. This 5 mL single-dose vial is labeled for use with dilution and warns against direct injection and mixing with calcium-containing solutions. Manufactured in India for AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel (4 mg per 5 mL (0.8 mg / mL))

Packaging label for Zoledronic Acid Injection 4 mg per 5 mL (0.8 mg/mL) concentrate for intravenous infusion after dilution. The label includes product information such as single-dose vial, dosage instructions (not for direct injection, must be diluted), storage conditions, and is labeled for prescription use only. It is distributed by AuroMedics Pharma LLC, with NDC 55150-266-05 and includes a barcode and lot code information.*

FDA Label Image

Zoledronic Acid Monohydrate Chemical Structure (Zoledronic Acid Str)

Chemical structure diagram of zoledronic acid, showing its molecular framework with two phosphonic acid groups, a hydroxyl group, and a nitrogen-containing heterocyclic ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.